MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction

Phase 1

Terminated

Conditions: Congestive Heart Failure
Renal Dysfunction

Interventions: Drug: low dose Nesiritide
Drug: nesiritide, Sildenafil

First Posted Date: 2009-01-08

Last Posted Date: 2010-09-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT00818701

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Range of Motion and Patients With Distal Radius Fractures

Not Applicable

Completed

Conditions: Radius Fractures

Interventions: Procedure: Physical Therapy

First Posted Date: 2009-01-06

Last Posted Date: 2011-04-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 39

Registration Number: NCT00816998

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2

Completed

Conditions: Lymphoma
Leukemia

Interventions: Biological: bevacizumab
Biological: pegfilgrastim
Biological: rituximab
Drug: cyclophosphamide
Drug: pentostatin

First Posted Date: 2009-01-01

Last Posted Date: 2017-06-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 68

Registration Number: NCT00816595

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Biological: allogeneic tumor cell vaccine
Biological: therapeutic autologous dendritic cells

First Posted Date: 2008-12-25

Last Posted Date: 2013-11-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2

Registration Number: NCT00814892

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States

Varenicline for the Treatment of Smokeless Tobacco

Not Applicable

Completed

Conditions: Nicotine Dependence

Interventions: Drug: placebo
Drug: varenicline

First Posted Date: 2008-12-23

Last Posted Date: 2012-07-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 76

Registration Number: NCT00813917

Locations: 🇺🇸
Nicotine Research Program, Rochester, Minnesota, United States

Space and Interaction Trial: Room Design and Patient-physician Interaction

Not Applicable

Completed

Conditions: Internal Medicine Patients
Participating Staff

Interventions: Other: Control room
Other: Re-designed room

First Posted Date: 2008-12-11

Last Posted Date: 2011-12-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT00806559

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Mayo Acute Stroke Trial for Enhancing Recovery

Phase 2

Completed

Conditions: Ischemic Stroke

Interventions: Drug: Donepezil

First Posted Date: 2008-12-10

Last Posted Date: 2021-07-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT00805792

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

Phase 1

Completed

Conditions: Idiopathic Membranous Nephropathy

Interventions: Drug: ACTH

First Posted Date: 2008-12-10

Last Posted Date: 2014-10-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT00805753

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇨🇦
University of Toronto, Toronto, Ontario, Canada

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

Phase 1

Terminated

Conditions: Prostate Cancer

Interventions: Biological: Ad5-CMV-NIS
Drug: liothyronine sodium
Genetic: reverse transcriptase-polymerase chain reaction
Other: laboratory biomarker analysis
Radiation: iodine I 131

First Posted Date: 2008-11-10

Last Posted Date: 2023-04-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 8

Registration Number: NCT00788307

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock

Phase 4

Completed

Conditions: Ventricular Tachycardia
Atrial Fibrillation
Ventricular Fibrillation
Supraventricular Tachycardia

Interventions: Device: Dual Chamber ICD
Device: Single Chamber ICD

First Posted Date: 2008-11-10

Last Posted Date: 2014-07-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT00787800

Locations: 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
🇮🇱
Carmel Medical Center, Haifa, Israel
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy